{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T05:54:47Z","timestamp":1789019687635,"version":"build-2803163510"},"reference-count":220,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacology & Therapeutics"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1016\/j.pharmthera.2016.10.014","type":"journal-article","created":{"date-parts":[[2016,10,20]],"date-time":"2016-10-20T22:47:20Z","timestamp":1477003640000},"page":"98-115","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":87,"special_numbering":"C","title":["Modulating putative endothelial progenitor cells for the treatment of endothelial dysfunction and cardiovascular complications in diabetes"],"prefix":"10.1016","volume":"170","author":[{"given":"Julien","family":"Wils","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Favre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e9r\u00e9my","family":"Bellien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.pharmthera.2016.10.014_bb0005","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1253\/circj.CJ-12-0897","article-title":"Prostacyclin stimulated integrin-dependent angiogenic effects of endothelial progenitor cells and mediated potent circulation recovery in ischemic hind limb model","volume":"77","author":"Aburakawa","year":"2013","journal-title":"Circ J"},{"issue":"4","key":"10.1016\/j.pharmthera.2016.10.014_bb0010","doi-asserted-by":"crossref","first-page":"833","DOI":"10.3892\/ijmm.2014.1630","article-title":"Priming with proangiogenic growth factors and endothelial progenitor cells improves revascularization in linear diabetic wounds","volume":"33","author":"Ackermann","year":"2014","journal-title":"Int J Mol Med"},{"issue":"11","key":"10.1016\/j.pharmthera.2016.10.014_bb0015","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1038\/nm948","article-title":"Essential role of endothelial nitric oxide synthase for mobilization of stem and progenitor cells","volume":"9","author":"Aicher","year":"2003","journal-title":"Nat Med"},{"issue":"4","key":"10.1016\/j.pharmthera.2016.10.014_bb0020","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.2337\/db13-0894","article-title":"Diabetes causes bone marrow autonomic neuropathy and impairs stem cell mobilization via dysregulated p66Shc and Sirt1","volume":"63","author":"Albiero","year":"2014","journal-title":"Diabetes"},{"issue":"11","key":"10.1016\/j.pharmthera.2016.10.014_bb0025","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1002\/stem.745","article-title":"Concise review: circulating endothelial progenitor cells for vascular medicine","volume":"29","author":"Asahara","year":"2011","journal-title":"Stem Cells"},{"issue":"5302","key":"10.1016\/j.pharmthera.2016.10.014_bb0030","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1126\/science.275.5302.964","article-title":"Isolation of putative progenitor endothelial cells for angiogenesis","volume":"275","author":"Asahara","year":"1997","journal-title":"Science"},{"issue":"9","key":"10.1016\/j.pharmthera.2016.10.014_bb0035","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1161\/01.RES.0000070067.64040.7C","article-title":"HMG-CoA reductase inhibitors reduce senescence and increase proliferation of endothelial progenitor cells via regulation of cell cycle regulatory genes","volume":"92","author":"Assmus","year":"2003","journal-title":"Circ Res"},{"issue":"4","key":"10.1016\/j.pharmthera.2016.10.014_bb0040","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1161\/01.HYP.0000159191.98140.89","article-title":"Stimulation of endothelial progenitor cells: a new putative therapeutic effect of angiotensin II receptor antagonists","volume":"45","author":"Bahlmann","year":"2005","journal-title":"Hypertension"},{"issue":"6","key":"10.1016\/j.pharmthera.2016.10.014_bb0045","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/j.bbapap.2008.03.004","article-title":"High glucose downregulates endothelial progenitor cell number via SIRT1","volume":"1784","author":"Balestrieri","year":"2008","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.pharmthera.2016.10.014_bb0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2015\/835934","article-title":"Are endothelial progenitor cells the real solution for cardiovascular diseases? Focus on controversies and perspectives","volume":"2015","author":"Balistreri","year":"2015","journal-title":"Biomed Res Int"},{"issue":"1","key":"10.1016\/j.pharmthera.2016.10.014_bb0055","first-page":"10","article-title":"Circulating and tissue resident endothelial progenitor cells","volume":"229","author":"Basile","year":"2014","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.pharmthera.2016.10.014_bb0060","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.phrs.2015.05.013","article-title":"Exploring the various aspects of the pathological role of vascular endothelial growth factor (VEGF) in diabetic retinopathy","volume":"99","author":"Behl","year":"2015","journal-title":"Pharmacol Res"},{"issue":"1","key":"10.1016\/j.pharmthera.2016.10.014_bb0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pharmthera.2011.03.015","article-title":"Modulation of cytochrome-derived epoxyeicosatrienoic acids pathway: a promising pharmacological approach to prevent endothelial dysfunction in cardiovascular diseases?","volume":"131","author":"Bellien","year":"2011","journal-title":"Pharmacol Ther"},{"issue":"9","key":"10.1016\/j.pharmthera.2016.10.014_bb0070","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1111\/j.1538-7836.2012.04835.x","article-title":"Priming of late endothelial progenitor cells with erythropoietin before transplantation requires the CD131 receptor subunit and enhances their angiogenic potential","volume":"10","author":"Bennis","year":"2012","journal-title":"J Thromb Haemost"},{"issue":"8","key":"10.1016\/j.pharmthera.2016.10.014_bb0075","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1007\/s00125-011-2191-8","article-title":"Regulation of hypoxia-inducible factor 1 and the loss of the cellular response to hypoxia in diabetes","volume":"54","author":"Bento","year":"2011","journal-title":"Diabetologia"},{"issue":"4","key":"10.1016\/j.pharmthera.2016.10.014_bb0080","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.dsx.2014.04.006","article-title":"The effect of angiotensin-2 receptor blocker valsartan on circulating level of endothelial progenitor cells in diabetic patients with asymptomatic coronary artery disease","volume":"9","author":"Berezin","year":"2015","journal-title":"Diabetes Metab Syndr"},{"issue":"9","key":"10.1016\/j.pharmthera.2016.10.014_bb0085","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1007\/s00125-015-3643-3","article-title":"Enhanced endoplasmic reticulum stress in bone marrow angiogenic progenitor cells in a mouse model of long-term experimental type 2 diabetes","volume":"58","author":"Bhatta","year":"2015","journal-title":"Diabetologia"},{"issue":"7","key":"10.1016\/j.pharmthera.2016.10.014_bb0090","doi-asserted-by":"crossref","first-page":"2664","DOI":"10.2337\/db14-1709","article-title":"Epigenetic regulation of placenta-specific 8 contributes to altered function of endothelial colony-forming cells exposed to intrauterine gestational diabetes mellitus","volume":"64","author":"Blue","year":"2015","journal-title":"Diabetes"},{"issue":"3","key":"10.1016\/j.pharmthera.2016.10.014_bb0095","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1161\/01.RES.0000111802.09964.EF","article-title":"Prevention and reversal of premature endothelial cell senescence and vasculopathy in obesity-induced diabetes by ebselen","volume":"94","author":"Brodsky","year":"2004","journal-title":"Circ Res"},{"issue":"10","key":"10.1016\/j.pharmthera.2016.10.014_bb0100","doi-asserted-by":"crossref","first-page":"2621","DOI":"10.2337\/db11-1768","article-title":"Ephrin-B2-activated peripheral blood mononuclear cells from diabetic patients restore diabetes-induced impairment of postischemic neovascularization","volume":"61","author":"Broqu\u00e8res-You","year":"2012","journal-title":"Diabetes"},{"issue":"1","key":"10.1016\/j.pharmthera.2016.10.014_bb0105","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1167\/iovs.08-1748","article-title":"Correlation of different circulating endothelial progenitor cells to stages of diabetic retinopathy: first in vivo data","volume":"50","author":"Brunner","year":"2009","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"10.1016\/j.pharmthera.2016.10.014_bb0110","doi-asserted-by":"crossref","first-page":"C145","DOI":"10.1152\/ajpcell.00350.2007","article-title":"AGE-receptor-1 counteracts cellular oxidant stress induced by AGEs via negative regulation of p66shc-dependent FKHRL1 phosphorylation","volume":"294","author":"Cai","year":"2008","journal-title":"Am J Phys Cell Physiol"},{"issue":"12","key":"10.1016\/j.pharmthera.2016.10.014_bb0115","doi-asserted-by":"crossref","first-page":"5217","DOI":"10.1073\/pnas.0609656104","article-title":"Genetic deletion of p66Shc adaptor protein prevents hyperglycemia-induced endothelial dysfunction and oxidative stress","volume":"104","author":"Camici","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"10.1016\/j.pharmthera.2016.10.014_bb0120","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/j.exphem.2007.04.002","article-title":"Human CD34+AC133+VEGFR-2+ cells are not endothelial progenitor cells but distinct, primitive hematopoietic progenitors","volume":"35","author":"Case","year":"2007","journal-title":"Exp Hematol"},{"issue":"8","key":"10.1016\/j.pharmthera.2016.10.014_bb0125","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1038\/nm1075","article-title":"Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1","volume":"10","author":"Ceradini","year":"2004","journal-title":"Nat Med"},{"issue":"16","key":"10.1016\/j.pharmthera.2016.10.014_bb0130","doi-asserted-by":"crossref","first-page":"10930","DOI":"10.1074\/jbc.M707451200","article-title":"Decreasing intracellular superoxide corrects defective ischemia-induced new vessel formation in diabetic mice","volume":"283","author":"Ceradini","year":"2008","journal-title":"J Biol Chem"},{"issue":"11","key":"10.1016\/j.pharmthera.2016.10.014_bb0135","doi-asserted-by":"crossref","first-page":"2949","DOI":"10.2337\/db10-0582","article-title":"Adiponectin prevents diabetic premature senescence of endothelial progenitor cells and promotes endothelial repair by suppressing the p38 MAP kinase\/p16INK4A signaling pathway","volume":"59","author":"Chang","year":"2010","journal-title":"Diabetes"},{"issue":"2","key":"10.1016\/j.pharmthera.2016.10.014_bb0140","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.bbrc.2009.02.040","article-title":"Advanced glycation end products impair function of late endothelial progenitor cells through effects on protein kinase Akt and cyclooxygenase-2","volume":"381","author":"Chen","year":"2009","journal-title":"Biochem Biophys Res Commun"},{"issue":"5","key":"10.1016\/j.pharmthera.2016.10.014_bb0145","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1097\/FJC.0b013e31819b5438","article-title":"C-reactive protein upregulates receptor for advanced glycation end products expression and alters antioxidant defenses in rat endothelial progenitor cells","volume":"53","author":"Chen","year":"2009","journal-title":"J Cardiovasc Pharmacol"},{"issue":"11","key":"10.1016\/j.pharmthera.2016.10.014_bb0150","doi-asserted-by":"crossref","first-page":"e50105","DOI":"10.1371\/journal.pone.0050105","article-title":"Transfusion of CXCR4-primed endothelial progenitor cells reduces cerebral ischemic damage and promotes repair in db\/db diabetic mice","volume":"7","author":"Chen","year":"2012","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.pharmthera.2016.10.014_bb0155","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1007\/s12020-010-9383-8","article-title":"Effects of metformin plus gliclazide compared with metformin alone on circulating endothelial progenitor cell in type 2 diabetic patients","volume":"38","author":"Chen","year":"2010","journal-title":"Endocrine"},{"issue":"6","key":"10.1016\/j.pharmthera.2016.10.014_bb0160","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.2337\/db06-1103","article-title":"High glucose impairs early and late endothelial progenitor cells by modifying nitric oxide-related but not oxidative stress-mediated mechanisms","volume":"56","author":"Chen","year":"2007","journal-title":"Diabetes"},{"issue":"3","key":"10.1016\/j.pharmthera.2016.10.014_bb0165","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1161\/HYPERTENSIONAHA.111.00202","article-title":"Angiotensin-converting enzyme 2 priming enhances the function of endothelial progenitor cells and their therapeutic efficacy","volume":"61","author":"Chen","year":"2013","journal-title":"Hypertension"},{"issue":"2\u20133","key":"10.1016\/j.pharmthera.2016.10.014_bb0170","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.ejphar.2011.02.044","article-title":"Effects of gliclazide on endothelial function in patients with newly diagnosed type 2 diabetes","volume":"659","author":"Chen","year":"2011","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmthera.2016.10.014_bb0175","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1472-6823-10-5","article-title":"Comparison of endothelial progenitor cell function in type 2 diabetes with good and poor glycemic control","volume":"10","author":"Churdchomjan","year":"2010","journal-title":"BMC Endocr Disord"},{"issue":"4","key":"10.1016\/j.pharmthera.2016.10.014_bb0180","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.2337\/db09-1187","article-title":"Downregulation of the longevity-associated protein sirtuin 1 in insulin resistance and metabolic syndrome: potential biochemical mechanisms","volume":"59","author":"de Kreutzenberg","year":"2010","journal-title":"Diabetes"},{"issue":"12","key":"10.1016\/j.pharmthera.2016.10.014_bb0185","doi-asserted-by":"crossref","first-page":"3591","DOI":"10.1182\/blood-2003-12-4103","article-title":"Antioxidative stress-associated genes in circulating progenitor cells: evidence for enhanced resistance against oxidative stress","volume":"104","author":"Dernbach","year":"2004","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.pharmthera.2016.10.014_bb0190","doi-asserted-by":"crossref","first-page":"875","DOI":"10.2337\/dc09-1468","article-title":"Circulating vascular progenitor cells in patients with type 1 diabetes and microalbuminuria","volume":"33","author":"Dessapt","year":"2010","journal-title":"Diabetes Care"},{"issue":"5","key":"10.1016\/j.pharmthera.2016.10.014_bb0195","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1160\/TH07-08-0509","article-title":"The prostacyclin analogue iloprost increases circulating endothelial progenitor cells in patients with critical limb ischemia","volume":"100","author":"Di Stefano","year":"2008","journal-title":"Thromb Haemost"},{"issue":"3","key":"10.1016\/j.pharmthera.2016.10.014_bb0200","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1093\/cvr\/cvp082","article-title":"p66ShcA modulates oxidative stress and survival of endothelial progenitor cells in response to high glucose","volume":"82","author":"Di Stefano","year":"2009","journal-title":"Cardiovasc Res"},{"issue":"3","key":"10.1016\/j.pharmthera.2016.10.014_bb0205","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1172\/JCI200113152","article-title":"HMG-CoA reductase inhibitors (statins) increase endothelial progenitor cells via the PI 3-kinase\/Akt pathway","volume":"108","author":"Dimmeler","year":"2001","journal-title":"J Clin Invest"},{"issue":"7","key":"10.1016\/j.pharmthera.2016.10.014_bb0210","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1172\/JCI18127","article-title":"Inhibition of GAPDH activity by poly(ADP-ribose) polymerase activates three major pathways of hyperglycemic damage in endothelial cells","volume":"112","author":"Du","year":"2003","journal-title":"J Clin Invest"},{"issue":"7","key":"10.1016\/j.pharmthera.2016.10.014_bb0215","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1007\/s00125-008-0939-6","article-title":"Generalised reduction of putative endothelial progenitors and CXCR4-positive peripheral blood cells in type 2 diabetes","volume":"51","author":"Egan","year":"2008","journal-title":"Diabetologia"},{"issue":"7","key":"10.1016\/j.pharmthera.2016.10.014_bb0220","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1038\/sj.bjp.0707142","article-title":"Nitropravastatin stimulates reparative neovascularisation and improves recovery from limb ischaemia in type-1 diabetic mice","volume":"150","author":"Emanueli","year":"2007","journal-title":"Br J Pharmacol"},{"issue":"3","key":"10.1016\/j.pharmthera.2016.10.014_bb0225","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1161\/HYPERTENSIONAHA.110.169193","article-title":"Angiotensin II impairs endothelial progenitor cell number and function in vitro and in vivo: implications for vascular regeneration","volume":"58","author":"Endtmann","year":"2011","journal-title":"Hypertension"},{"issue":"9","key":"10.1016\/j.pharmthera.2016.10.014_bb0230","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1002\/cyto.a.20921","article-title":"Application of polychromatic flow cytometry to identify novel subsets of circulating cells with angiogenic potential","volume":"77","author":"Estes","year":"2010","journal-title":"Cytometry A"},{"issue":"7","key":"10.1016\/j.pharmthera.2016.10.014_bb0240","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.2337\/dc10-0187","article-title":"The oral dipeptidyl peptidase-4 inhibitor sitagliptin increases circulating endothelial progenitor cells in patients with type 2 diabetes: possible role of stromal-derived factor-1alpha","volume":"33","author":"Fadini","year":"2010","journal-title":"Diabetes Care"},{"issue":"5","key":"10.1016\/j.pharmthera.2016.10.014_bb0245","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.2337\/dc09-1999","article-title":"Time course and mechanisms of circulating progenitor cell reduction in the natural history of type 2 diabetes","volume":"33","author":"Fadini","year":"2010","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.pharmthera.2016.10.014_bb0250","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.atherosclerosis.2009.08.033","article-title":"Autologous stem cell therapy for peripheral arterial disease meta-analysis and systematic review of the literature","volume":"209","author":"Fadini","year":"2010","journal-title":"Atherosclerosis"},{"issue":"7","key":"10.1016\/j.pharmthera.2016.10.014_bb0255","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1007\/s40618-015-0247-1","article-title":"Hypoglycemia affects the changes in endothelial progenitor cell levels during insulin therapy in type 2 diabetic patients","volume":"38","author":"Fadini","year":"2015","journal-title":"J Endocrinol Investig"},{"issue":"4","key":"10.1016\/j.pharmthera.2016.10.014_bb0260","doi-asserted-by":"crossref","first-page":"943","DOI":"10.2337\/dc12-1084","article-title":"Diabetes impairs stem cell and proangiogenic cell mobilization in humans","volume":"36","author":"Fadini","year":"2013","journal-title":"Diabetes Care"},{"issue":"8","key":"10.1016\/j.pharmthera.2016.10.014_bb0265","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1111\/j.1463-1326.2011.01396.x","article-title":"Optimized glycaemic control achieved with add-on basal insulin therapy improves indexes of endothelial damage and regeneration in type 2 diabetic patients with macroangiopathy: a randomized crossover trial comparing detemir versus glargine","volume":"13","author":"Fadini","year":"2011","journal-title":"Diabetes Obes Metab"},{"issue":"8","key":"10.1016\/j.pharmthera.2016.10.014_bb0270","doi-asserted-by":"crossref","first-page":"2969","DOI":"10.2337\/db15-0077","article-title":"Diabetes limits stem cell mobilization following G-CSF but not plerixafor","volume":"64","author":"Fadini","year":"2015","journal-title":"Diabetes"},{"issue":"4","key":"10.1016\/j.pharmthera.2016.10.014_bb0275","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1161\/CIRCRESAHA.111.243386","article-title":"Critical reevaluation of endothelial progenitor cell phenotypes for therapeutic and diagnostic use","volume":"110","author":"Fadini","year":"2012","journal-title":"Circ Res"},{"issue":"9","key":"10.1016\/j.pharmthera.2016.10.014_bb0280","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1016\/j.jacc.2004.11.067","article-title":"Circulating endothelial progenitor cells are reduced in peripheral vascular complications of type 2 diabetes mellitus","volume":"45","author":"Fadini","year":"2005","journal-title":"J Am Coll Cardiol"},{"issue":"10","key":"10.1016\/j.pharmthera.2016.10.014_bb0285","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1007\/s00125-007-0732-y","article-title":"Glucose tolerance is negatively associated with circulating progenitor cell levels","volume":"50","author":"Fadini","year":"2007","journal-title":"Diabetologia"},{"key":"10.1016\/j.pharmthera.2016.10.014_bb0290","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.vph.2014.11.005","article-title":"Short-term statin discontinuation increases endothelial progenitor cells without inflammatory rebound in type 2 diabetic patients","volume":"67-69","author":"Fadini","year":"2015","journal-title":"Vasc Pharmacol"},{"issue":"9","key":"10.1016\/j.pharmthera.2016.10.014_bb0295","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1161\/01.ATV.0000237750.44469.88","article-title":"Number and function of endothelial progenitor cells as a marker of severity for diabetic vasculopathy","volume":"26","author":"Fadini","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"1","key":"10.1016\/j.pharmthera.2016.10.014_bb0300","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1111\/eci.12009","article-title":"The diverse identity of angiogenic monocytes: the diverse identity of angiogenic monocytes","volume":"43","author":"Favre","year":"2013","journal-title":"Eur J Clin Investig"},{"key":"10.1016\/j.pharmthera.2016.10.014_bb0305","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.vph.2015.08.003","article-title":"Palmitic acid increases pro-oxidant adaptor protein p66Shc expression and affects vascularization factors in angiogenic mononuclear cells: action of resveratrol","volume":"75","author":"Favre","year":"2015","journal-title":"Vasc Pharmacol"},{"issue":"9","key":"10.1016\/j.pharmthera.2016.10.014_bb0310","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.2337\/dci15-0012","article-title":"Update on prevention of cardiovascular disease in adults with type 2 diabetes mellitus in light of recent evidence: a scientific statement from the American Heart Association and the American Diabetes Association","volume":"38","author":"Fox","year":"2015","journal-title":"Diabetes Care"},{"issue":"9","key":"10.1016\/j.pharmthera.2016.10.014_bb0315","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1111\/febs.13183","article-title":"Epigenetic regulation of endothelial-cell-mediated vascular repair","volume":"282","author":"Fraineau","year":"2015","journal-title":"FEBS J"},{"issue":"5","key":"10.1016\/j.pharmthera.2016.10.014_bb0320","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1172\/JCI29710","article-title":"Diabetic impairments in NO-mediated endothelial progenitor cell mobilization and homing are reversed by hyperoxia and SDF-1\u03b1","volume":"117","author":"Gallagher","year":"2007","journal-title":"J Clin Invest"},{"issue":"5","key":"10.1016\/j.pharmthera.2016.10.014_bb0325","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.ahj.2012.07.031","article-title":"Erythropoietin treatment in patients with acute myocardial infarction: a meta-analysis of randomized controlled trials","volume":"164","author":"Gao","year":"2012","journal-title":"Am Heart J"},{"issue":"9","key":"10.1016\/j.pharmthera.2016.10.014_bb0330","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1089\/ars.2010.3147","article-title":"The lifespan-regulator p66Shc in mitochondria: redox enzyme or redox sensor?","volume":"13","author":"Gertz","year":"2010","journal-title":"Antioxid Redox Signal"},{"issue":"2","key":"10.1016\/j.pharmthera.2016.10.014_bb0335","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.cell.2005.05.011","article-title":"Electron transfer between cytochrome c and p66Shc generates reactive oxygen species that trigger mitochondrial apoptosis","volume":"122","author":"Giorgio","year":"2005","journal-title":"Cell"},{"issue":"10","key":"10.1016\/j.pharmthera.2016.10.014_bb0340","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1161\/CIRCRESAHA.116.308332","article-title":"Endogenous transmembrane TNF-alpha protects against premature senescence in endothelial colony forming cells","volume":"118","author":"Green","year":"2016","journal-title":"Circ Res"},{"issue":"11","key":"10.1016\/j.pharmthera.2016.10.014_bb0345","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1161\/01.RES.0000105569.77539.21","article-title":"Diverse origin and function of cells with endothelial phenotype obtained from adult human blood","volume":"93","author":"Gulati","year":"2003","journal-title":"Circ Res"},{"issue":"3","key":"10.1016\/j.pharmthera.2016.10.014_bb0350","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.thromres.2010.03.002","article-title":"Hyperglycemia and oxidized-LDL exert a deleterious effect on endothelial progenitor cell migration in type 2 diabetes mellitus","volume":"126","author":"Hamed","year":"2010","journal-title":"Thromb Res"},{"issue":"1","key":"10.1016\/j.pharmthera.2016.10.014_bb0355","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/1475-2840-8-56","article-title":"Nitric oxide and superoxide dismutase modulate endothelial progenitor cell function in type 2 diabetes mellitus","volume":"8","author":"Hamed","year":"2009","journal-title":"Cardiovasc Diabetol"},{"issue":"10","key":"10.1016\/j.pharmthera.2016.10.014_bb0360","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1161\/CIRCULATIONAHA.108.777169","article-title":"Peroxisome proliferator-activated receptor-delta agonist enhances vasculogenesis by regulating endothelial progenitor cells through genomic and nongenomic activations of the phosphatidylinositol 3-kinase\/Akt pathway","volume":"118","author":"Han","year":"2008","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.pharmthera.2016.10.014_bb0365","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1161\/CIRCRESAHA.108.176057","article-title":"Angiogenic function of prostacyclin biosynthesis in human endothelial progenitor cells","volume":"103","author":"He","year":"2008","journal-title":"Circ Res"},{"issue":"11","key":"10.1016\/j.pharmthera.2016.10.014_bb0370","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1161\/01.ATV.0000142810.27849.8f","article-title":"Human endothelial progenitor cells tolerate oxidative stress due to intrinsically high expression of manganese superoxide dismutase","volume":"24","author":"He","year":"2004","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"11","key":"10.1016\/j.pharmthera.2016.10.014_bb0375","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1161\/ATVBAHA.110.211581","article-title":"Nitric oxide synthase expression and functional response to nitric oxide are both important modulators of circulating angiogenic cell response to angiogenic stimuli","volume":"30","author":"Heiss","year":"2010","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"7","key":"10.1016\/j.pharmthera.2016.10.014_bb0385","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1056\/NEJMoa022287","article-title":"Circulating endothelial progenitor cells, vascular function, and cardiovascular risk","volume":"348","author":"Hill","year":"2003","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.pharmthera.2016.10.014_bb0390","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.atherosclerosis.2008.12.036","article-title":"Telmisartan induces proliferation of human endothelial progenitor cells via PPARgamma-dependent PI3K\/Akt pathway","volume":"205","author":"Honda","year":"2009","journal-title":"Atherosclerosis"},{"issue":"6","key":"10.1016\/j.pharmthera.2016.10.014_bb0395","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.2337\/dc12-1206","article-title":"Endothelial progenitor cells are related to glycemic control in children with type 1 diabetes over time","volume":"36","author":"Hortenhuber","year":"2013","journal-title":"Diabetes Care"},{"issue":"4","key":"10.1016\/j.pharmthera.2016.10.014_bb0400","doi-asserted-by":"crossref","first-page":"H455","DOI":"10.1152\/ajpheart.00726.2015","article-title":"Stem cell-based therapies to promote angiogenesis in ischemic cardiovascular disease","volume":"310","author":"Hou","year":"2016","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"3","key":"10.1016\/j.pharmthera.2016.10.014_bb0405","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s10456-012-9267-z","article-title":"Niacin improves ischemia-induced neovascularization in diabetic mice by enhancement of endothelial progenitor cell functions independent of changes in plasma lipids","volume":"15","author":"Huang","year":"2012","journal-title":"Angiogenesis"},{"issue":"7","key":"10.1016\/j.pharmthera.2016.10.014_bb0410","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1111\/j.1476-5381.2012.02102.x","article-title":"Dipeptidyl peptidase-4 inhibitor improves neovascularization by increasing circulating endothelial progenitor cells","volume":"167","author":"Huang","year":"2012","journal-title":"Br J Pharmacol"},{"issue":"9","key":"10.1016\/j.pharmthera.2016.10.014_bb0415","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.2337\/diacare.28.9.2155","article-title":"Autologous transplantation of granulocyte colony-stimulating factor-mobilized peripheral blood mononuclear cells improves critical limb ischemia in diabetes","volume":"28","author":"Huang","year":"2005","journal-title":"Diabetes Care"},{"issue":"2","key":"10.1016\/j.pharmthera.2016.10.014_bb0420","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1161\/01.ATV.0000114236.77009.06","article-title":"Characterization of two types of endothelial progenitor cells and their different contributions to neovasculogenesis","volume":"24","author":"Hur","year":"2004","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"7","key":"10.1016\/j.pharmthera.2016.10.014_bb0425","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1111\/j.1440-1681.2004.04022.x","article-title":"Oxidized low-density lipoprotein induces endothelial progenitor cell senescence, leading to cellular dysfunction","volume":"31","author":"Imanishi","year":"2004","journal-title":"Clin Exp Pharmacol Physiol"},{"issue":"9","key":"10.1016\/j.pharmthera.2016.10.014_bb0430","doi-asserted-by":"crossref","first-page":"2752","DOI":"10.1182\/blood-2004-04-1396","article-title":"Identification of a novel hierarchy of endothelial progenitor cells using human peripheral and umbilical cord blood","volume":"104","author":"Ingram","year":"2004","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.pharmthera.2016.10.014_bb0435","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1182\/blood-2005-04-1509","article-title":"Unresolved questions, changing definitions, and novel paradigms for defining endothelial progenitor cells","volume":"106","author":"Ingram","year":"2005","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.pharmthera.2016.10.014_bb0440","doi-asserted-by":"crossref","first-page":"724","DOI":"10.2337\/db07-1507","article-title":"In vitro hyperglycemia or a diabetic intrauterine environment reduces neonatal endothelial colony-forming cell numbers and function","volume":"57","author":"Ingram","year":"2008","journal-title":"Diabetes"},{"issue":"10","key":"10.1016\/j.pharmthera.2016.10.014_bb0445","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1161\/CIRCULATIONAHA.105.541268","article-title":"Dose-dependent contribution of CD34-positive cell transplantation to concurrent vasculogenesis and cardiomyogenesis for functional regenerative recovery after myocardial infarction","volume":"113","author":"Iwasaki","year":"2006","journal-title":"Circulation"},{"issue":"8","key":"10.1016\/j.pharmthera.2016.10.014_bb0450","doi-asserted-by":"crossref","first-page":"5093","DOI":"10.1167\/iovs.10-70911","article-title":"Blockade of NADPH oxidase restores vasoreparative function in diabetic CD34+ cells","volume":"52","author":"Jarajapu","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"4","key":"10.1016\/j.pharmthera.2016.10.014_bb0455","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1111\/j.1365-2796.2009.02151.x","article-title":"Effects of atorvastatin on circulating CD34+\/CD133+\/CD45\u2212 progenitor cells and indices of angiogenesis (vascular endothelial growth factor and the angiopoietins 1 and 2) in atherosclerotic vascular disease and diabetes mellitus","volume":"267","author":"Jaumdally","year":"2010","journal-title":"J Intern Med"},{"issue":"2","key":"10.1016\/j.pharmthera.2016.10.014_bb0460","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/j.ijcard.2012.10.032","article-title":"Endothelial progenitor cells in relation to endothelin-1 and endothelin receptor blockade: a randomized, controlled trial","volume":"168","author":"Jung","year":"2013","journal-title":"Int J Cardiol"},{"issue":"4","key":"10.1016\/j.pharmthera.2016.10.014_bb0465","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.pharep.2015.05.017","article-title":"The real face of endothelial progenitor cells \u2014 circulating angiogenic cells as endothelial prognostic marker?","volume":"67","author":"Kachamakova-Trojanowska","year":"2015","journal-title":"Pharmacol Rep"},{"issue":"4","key":"10.1016\/j.pharmthera.2016.10.014_bb0470","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.2337\/db10-1080","article-title":"Insulin resistance impairs circulating angiogenic progenitor cell function and delays endothelial regeneration","volume":"60","author":"Kahn","year":"2011","journal-title":"Diabetes"},{"issue":"7","key":"10.1016\/j.pharmthera.2016.10.014_bb0475","doi-asserted-by":"crossref","first-page":"3422","DOI":"10.1073\/pnas.97.7.3422","article-title":"Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization","volume":"97","author":"Kalka","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10.1016\/j.pharmthera.2016.10.014_bb0480","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1091\/mbc.E05-06-0570","article-title":"Rac1 leads to phosphorylation-dependent increase in stability of the p66shc adaptor protein: role in Rac1-induced oxidative stress","volume":"17","author":"Khanday","year":"2006","journal-title":"Mol Biol Cell"},{"issue":"5","key":"10.1016\/j.pharmthera.2016.10.014_bb0485","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1161\/CIRCRESAHA.110.218396","article-title":"CD31+ cells represent highly angiogenic and vasculogenic cells in bone marrow: novel role of nonendothelial CD31+ cells in neovascularization and their therapeutic effects on ischemic vascular disease","volume":"107","author":"Kim","year":"2010","journal-title":"Circ Res"},{"issue":"7","key":"10.1016\/j.pharmthera.2016.10.014_bb0490","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.jacc.2010.01.070","article-title":"Human peripheral blood-derived CD31+ cells have robust angiogenic and vasculogenic properties and are effective for treating ischemic vascular disease","volume":"56","author":"Kim","year":"2010","journal-title":"J Am Coll Cardiol"},{"issue":"22","key":"10.1016\/j.pharmthera.2016.10.014_bb0495","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1161\/CIRCULATIONAHA.109.856815","article-title":"Priming with angiopoietin-1 augments the vasculogenic potential of the peripheral blood stem cells mobilized with granulocyte colony-stimulating factor through a novel Tie2\/Ets-1 pathway","volume":"120","author":"Kim","year":"2009","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.pharmthera.2016.10.014_bb0500","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1161\/01.ATV.0000156401.04325.8f","article-title":"Hyperglycemia reduces survival and impairs function of circulating blood-derived progenitor cells","volume":"25","author":"Kr\u00e4nkel","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"8","key":"10.1016\/j.pharmthera.2016.10.014_bb0505","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1253\/circj.70.1076","article-title":"Hyperglycemia accelerated endothelial progenitor cell senescence via the activation of p38 mitogen-activated protein kinase","volume":"70","author":"Kuki","year":"2006","journal-title":"Circ J"},{"issue":"12","key":"10.1016\/j.pharmthera.2016.10.014_bb0510","doi-asserted-by":"crossref","first-page":"4344","DOI":"10.1096\/fj.09-138743","article-title":"Transcriptional repression of Kruppel like factor-2 by the adaptor protein p66shc","volume":"23","author":"Kumar","year":"2009","journal-title":"FASEB J"},{"issue":"6","key":"10.1016\/j.pharmthera.2016.10.014_bb0515","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1186\/scrt382","article-title":"Difference in mobilization of progenitor cells after myocardial infarction in smoking versus non-smoking patients: insights from the BONAMI trial","volume":"4","author":"Lamirault","year":"2013","journal-title":"Stem Cell Res Ther"},{"issue":"2","key":"10.1016\/j.pharmthera.2016.10.014_bb0520","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1111\/j.1476-5381.2012.01857.x","article-title":"Revisiting cardiovascular regeneration with bone marrow-derived angiogenic and vasculogenic cells","volume":"169","author":"Lee","year":"2013","journal-title":"Br J Pharmacol"},{"issue":"6","key":"10.1016\/j.pharmthera.2016.10.014_bb0525","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1177\/2040622315598502","article-title":"Cardiovascular disease and type 1 diabetes: prevalence, prediction and management in an ageing population","volume":"6","author":"Lee","year":"2015","journal-title":"Ther Adv Chron Dis"},{"issue":"2","key":"10.1016\/j.pharmthera.2016.10.014_bb0530","doi-asserted-by":"crossref","first-page":"652","DOI":"10.2337\/db10-0240","article-title":"Adiponectin pretreatment counteracts the detrimental effect of a diabetic environment on endothelial progenitors","volume":"60","author":"Leicht","year":"2011","journal-title":"Diabetes"},{"issue":"9","key":"10.1016\/j.pharmthera.2016.10.014_bb0535","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1177\/2047487313488300","article-title":"Effect of intensive glycaemic control on endothelial progenitor cells in patients with long-standing uncontrolled type 2 diabetes","volume":"21","author":"Lev","year":"2014","journal-title":"Eur J Prev Cardiol"},{"issue":"10","key":"10.1016\/j.pharmthera.2016.10.014_bb0540","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1161\/CIRCULATIONAHA.112.108159","article-title":"Endothelium-selective activation of AMP-activated protein kinase prevents diabetes mellitus-induced impairment in vascular function and reendothelialization via induction of heme oxygenase-1 in mice","volume":"126","author":"Li","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2016.10.014_bb0545","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/1475-2840-11-46","article-title":"Advanced glycation end products impair the migration, adhesion and secretion potentials of late endothelial progenitor cells","volume":"11","author":"Li","year":"2012","journal-title":"Cardiovasc Diabetol"},{"issue":"8","key":"10.1016\/j.pharmthera.2016.10.014_bb0555","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1111\/j.1476-5381.2009.00450.x","article-title":"Rosiglitazone via upregulation of Akt\/eNOS pathways attenuates dysfunction of endothelial progenitor cells, induced by advanced glycation end products","volume":"158","author":"Liang","year":"2009","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pharmthera.2016.10.014_bb0560","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/s12933-014-0111-1","article-title":"Effects of pitavastatin versus atorvastatin on the peripheral endothelial progenitor cells and vascular endothelial growth factor in high-risk patients: a pilot prospective, double-blind, randomized study","volume":"13","author":"Lin","year":"2014","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"10.1016\/j.pharmthera.2016.10.014_bb0565","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1172\/JCI8071","article-title":"Origins of circulating endothelial cells and endothelial outgrowth from blood","volume":"105","author":"Lin","year":"2000","journal-title":"J Clin Invest"},{"issue":"3","key":"10.1016\/j.pharmthera.2016.10.014_bb0575","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1172\/JCI200113131","article-title":"HMG-CoA reductase inhibitor mobilizes bone marrow-derived endothelial progenitor cells","volume":"108","author":"Llevadot","year":"2001","journal-title":"J Clin Invest"},{"issue":"1","key":"10.1016\/j.pharmthera.2016.10.014_bb0580","doi-asserted-by":"crossref","first-page":"195","DOI":"10.2337\/diabetes.53.1.195","article-title":"Endothelial progenitor cell dysfunction a novel concept in the pathogenesis of vascular complications of type 1 diabetes","volume":"53","author":"Loomans","year":"2004","journal-title":"Diabetes"},{"issue":"6","key":"10.1016\/j.pharmthera.2016.10.014_bb0585","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1194\/jlr.M500507-JLR200","article-title":"Oxidized low density lipoprotein impairs endothelial progenitor cells by regulation of endothelial nitric oxide synthase","volume":"47","author":"Ma","year":"2006","journal-title":"J Lipid Res"},{"issue":"7","key":"10.1016\/j.pharmthera.2016.10.014_bb0590","doi-asserted-by":"crossref","first-page":"4518","DOI":"10.1074\/jbc.M111.286591","article-title":"Inhibition of insulin signaling in endothelial cells by protein kinase C-induced phosphorylation of p85 subunit of phosphatidylinositol 3-kinase (PI3K)","volume":"287","author":"Maeno","year":"2012","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2016.10.014_bb0595","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2014\/193095","article-title":"Nitric oxide, oxidative stress, and p66Shc interplay in diabetic endothelial dysfunction","volume":"2014","author":"Magenta","year":"2014","journal-title":"Biomed Res Int"},{"issue":"2","key":"10.1016\/j.pharmthera.2016.10.014_bb0600","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s12020-014-0478-5","article-title":"Circulating endothelial progenitor cells in type 1 diabetic patients with erectile dysfunction","volume":"49","author":"Maiorino","year":"2015","journal-title":"Endocrine"},{"issue":"2","key":"10.1016\/j.pharmthera.2016.10.014_bb0605","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1007\/s12020-015-0686-7","article-title":"Reducing glucose variability with continuous subcutaneous insulin infusion increases endothelial progenitor cells in type 1 diabetes: an observational study","volume":"52","author":"Maiorino","year":"2016","journal-title":"Endocrine"},{"issue":"4","key":"10.1016\/j.pharmthera.2016.10.014_bb0610","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1111\/jdi.12310","article-title":"Decreased levels of circulating CD34+ cells are associated with coronary heart disease in Japanese patients with type 2 diabetes","volume":"6","author":"Makino","year":"2015","journal-title":"J Diabetes Investig"},{"issue":"2b","key":"10.1016\/j.pharmthera.2016.10.014_bb0615","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1111\/j.1476-5381.2011.01423.x","article-title":"Nitric oxide-donating statin improves multiple functions of circulating angiogenic cells","volume":"164","author":"Mangialardi","year":"2011","journal-title":"Br J Pharmacol"},{"issue":"8","key":"10.1016\/j.pharmthera.2016.10.014_bb0620","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.2337\/db06-0369","article-title":"Benfotiamine counteracts glucose toxicity effects on endothelial progenitor cell differentiation via Akt\/FoxO signaling","volume":"55","author":"Marchetti","year":"2006","journal-title":"Diabetes"},{"issue":"12","key":"10.1016\/j.pharmthera.2016.10.014_bb0625","doi-asserted-by":"crossref","first-page":"4207","DOI":"10.1172\/JCI36858","article-title":"Manganese superoxide dismutase expression in endothelial progenitor cells accelerates wound healing in diabetic mice","volume":"120","author":"Marrotte","year":"2010","journal-title":"J Clin Invest"},{"issue":"9","key":"10.1016\/j.pharmthera.2016.10.014_bb0630","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.2119\/molmed.2011.00129","article-title":"Myeloid angiogenic cells act as alternative M2 macrophages and modulate angiogenesis through interleukin-8","volume":"17","author":"Medina","year":"2011","journal-title":"Mol Med"},{"issue":"1","key":"10.1016\/j.pharmthera.2016.10.014_bb0635","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.ajpath.2010.11.043","article-title":"Endothelial nitric oxide synthase overexpression restores the efficiency of bone marrow mononuclear cell-based therapy","volume":"178","author":"Mees","year":"2011","journal-title":"Am J Pathol"},{"issue":"7","key":"10.1016\/j.pharmthera.2016.10.014_bb0640","doi-asserted-by":"crossref","first-page":"e68611","DOI":"10.1371\/journal.pone.0068611","article-title":"Downregulation of microRNA-130a contributes to endothelial progenitor cell dysfunction in diabetic patients via its target Runx3","volume":"8","author":"Meng","year":"2013","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.pharmthera.2016.10.014_bb0645","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.yjmcc.2012.04.003","article-title":"Downregulation of microRNA-126 in endothelial progenitor cells from diabetes patients, impairs their functional properties, via target gene Spred-1","volume":"53","author":"Meng","year":"2012","journal-title":"J Mol Cell Cardiol"},{"issue":"6759","key":"10.1016\/j.pharmthera.2016.10.014_bb0650","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/46311","article-title":"The p66shc adaptor protein controls oxidative stress response and life span in mammals","volume":"402","author":"Migliaccio","year":"1999","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.pharmthera.2016.10.014_bb0655","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1182\/blood-2012-01-407106","article-title":"AngiomiR-126 expression and secretion from circulating CD34+ and CD14+ PBMCs: role for proangiogenic effects and alterations in type 2 diabetics","volume":"121","author":"Mocharla","year":"2013","journal-title":"Blood"},{"issue":"18","key":"10.1016\/j.pharmthera.2016.10.014_bb0660","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1136\/hrt.2010.220798","article-title":"Darbepoetin improves endothelial function and increases circulating endothelial progenitor cell number in patients with coronary artery disease","volume":"97","author":"Mueller","year":"2011","journal-title":"Heart"},{"issue":"4","key":"10.1016\/j.pharmthera.2016.10.014_bb0665","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1161\/01.ATV.0000258788.11372.d0","article-title":"Vascular dysfunction and reduced circulating endothelial progenitor cells in young healthy UK south Asian men","volume":"27","author":"Murphy","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"3","key":"10.1016\/j.pharmthera.2016.10.014_bb0670","doi-asserted-by":"crossref","first-page":"116","DOI":"10.3109\/13813455.2011.562513","article-title":"p66Shc, a multifaceted protein linking Erk signalling, glucose metabolism, and oxidative stress","volume":"117","author":"Natalicchio","year":"2011","journal-title":"Arch Physiol Biochem"},{"issue":"5564","key":"10.1016\/j.pharmthera.2016.10.014_bb0675","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.1126\/science.1069004","article-title":"Redox regulation of forkhead proteins through a p66shc-dependent signaling pathway","volume":"295","author":"Nemoto","year":"2002","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.pharmthera.2016.10.014_bb0680","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1253\/circj.CJ-08-0123","article-title":"Antioxidant therapy attenuates diabetes-related impairment of bone marrow stem cells","volume":"73","author":"Ohshima","year":"2009","journal-title":"Circ J"},{"issue":"11","key":"10.1016\/j.pharmthera.2016.10.014_bb0685","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1161\/CIRCRESAHA.111.247304","article-title":"Epigenetic regulation of endothelial lineage committed genes in pro-angiogenic hematopoietic and endothelial progenitor cells","volume":"109","author":"Ohtani","year":"2011","journal-title":"Circ Res"},{"issue":"7477","key":"10.1016\/j.pharmthera.2016.10.014_bb0690","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/nature12656","article-title":"A small-molecule AdipoR agonist for type 2 diabetes and short life in obesity","volume":"503","author":"Okada-Iwabu","year":"2013","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.pharmthera.2016.10.014_bb0695","doi-asserted-by":"crossref","first-page":"H724","DOI":"10.1152\/ajpheart.00739.2011","article-title":"Novel role of p66Shc in ROS-dependent VEGF signaling and angiogenesis in endothelial cells","volume":"302","author":"Oshikawa","year":"2012","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"2","key":"10.1016\/j.pharmthera.2016.10.014_bb0700","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1210\/jc.2004-1283","article-title":"Diabetes induces p66shc gene expression in human peripheral blood mononuclear cells: relationship to oxidative stress","volume":"90","author":"Pagnin","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"issue":"88","key":"10.1016\/j.pharmthera.2016.10.014_bb0705","first-page":"1475","article-title":"Circulating endothelial progenitor cells and large artery structure and function in young subjects with uncomplicated type 1 diabetes","volume":"10","author":"Palombo","year":"2011","journal-title":"Cardiovasc Diabetol"},{"issue":"22","key":"10.1016\/j.pharmthera.2016.10.014_bb0710","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1093\/eurheartj\/ehw073","article-title":"Reprogramming ageing and longevity genes restores paracrine angiogenic properties of early outgrowth cells","volume":"37","author":"Paneni","year":"2016","journal-title":"Eur Heart J"},{"issue":"3","key":"10.1016\/j.pharmthera.2016.10.014_bb0715","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1161\/CIRCRESAHA.112.266593","article-title":"Gene silencing of the mitochondrial adaptor p66shc suppresses vascular hyperglycemic memory in diabetes","volume":"111","author":"Paneni","year":"2012","journal-title":"Circ Res"},{"key":"10.1016\/j.pharmthera.2016.10.014_bb0720","doi-asserted-by":"crossref","DOI":"10.1111\/bph.13225","article-title":"Angiotensin-(1-7) administration benefits cardiac, renal and progenitor cell function in db\/db mice","author":"Papinska","year":"2015","journal-title":"Br J Pharmacol"},{"issue":"2","key":"10.1016\/j.pharmthera.2016.10.014_bb0725","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1161\/CIRCRESAHA.116.304187","article-title":"Circulating CD34+ progenitor cells and risk of mortality in a population with coronary artery disease","volume":"116","author":"Patel","year":"2015","journal-title":"Circ Res"},{"issue":"16","key":"10.1016\/j.pharmthera.2016.10.014_bb0730","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1001\/jama.2012.418","article-title":"Effect of transendocardial delivery of autologous bone marrow mononuclear cells on functional capacity, left ventricular function, and perfusion in chronic heart failure: The FOCUS-CCTRN trial","volume":"307","author":"Perin","year":"2012","journal-title":"JAMA"},{"issue":"12","key":"10.1016\/j.pharmthera.2016.10.014_bb0735","doi-asserted-by":"crossref","first-page":"2690","DOI":"10.1111\/j.1600-6143.2010.03309.x","article-title":"Improved function of circulating angiogenic cells is evident in type 1 diabetic islet-transplanted patients","volume":"10","author":"Petrelli","year":"2010","journal-title":"Am J Transplant"},{"issue":"5812","key":"10.1016\/j.pharmthera.2016.10.014_bb0740","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1126\/science.1135380","article-title":"Protein kinase C beta and prolyl isomerase 1 regulate mitochondrial effects of the life-span determinant p66Shc","volume":"315","author":"Pinton","year":"2007","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.pharmthera.2016.10.014_bb0745","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.atherosclerosis.2005.03.039","article-title":"PPARgamma-agonist rosiglitazone increases number and migratory activity of cultured endothelial progenitor cells","volume":"183","author":"Pistrosch","year":"2005","journal-title":"Atherosclerosis"},{"issue":"1","key":"10.1016\/j.pharmthera.2016.10.014_bb0750","doi-asserted-by":"crossref","DOI":"10.1186\/s13148-015-0090-4","article-title":"Epigenetic mechanisms of endothelial dysfunction in type 2 diabetes","volume":"7","author":"Prattichizzo","year":"2015","journal-title":"Clin Epigenetics"},{"key":"10.1016\/j.pharmthera.2016.10.014_bb0755","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.cca.2015.06.017","article-title":"MicroRNAs: key regulators of endothelial progenitor cell functions","volume":"448","author":"Qu","year":"2015","journal-title":"Clin Chim Acta"},{"issue":"3","key":"10.1016\/j.pharmthera.2016.10.014_bb0760","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1007\/s00125-011-2415-y","article-title":"The endothelin receptor antagonist bosentan improves peripheral endothelial function in patients with type 2 diabetes mellitus and microalbuminuria: a randomised trial","volume":"55","author":"Rafnsson","year":"2012","journal-title":"Diabetologia"},{"key":"10.1016\/j.pharmthera.2016.10.014_bb0765","doi-asserted-by":"crossref","first-page":"436879","DOI":"10.1155\/2015\/436879","article-title":"Epigenetic changes in endothelial progenitors as a possible cellular basis for glycemic memory in diabetic vascular complications","volume":"2015","author":"Rajasekar","year":"2015","journal-title":"J Diabetes Res"},{"issue":"1","key":"10.1016\/j.pharmthera.2016.10.014_bb0770","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1093\/ajh\/hpu119","article-title":"Effect of aliskiren on circulating endothelial progenitor cells and vascular function in patients with type 2 diabetes and essential hypertension","volume":"28","author":"Raptis","year":"2015","journal-title":"Am J Hypertens"},{"issue":"10","key":"10.1016\/j.pharmthera.2016.10.014_bb0775","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1007\/s00125-010-1843-4","article-title":"Multifactorial treatment increases endothelial progenitor cells in patients with type 2 diabetes","volume":"53","author":"Reinhard","year":"2010","journal-title":"Diabetologia"},{"issue":"7","key":"10.1016\/j.pharmthera.2016.10.014_bb0780","doi-asserted-by":"crossref","first-page":"2666","DOI":"10.1210\/jc.2015-1687","article-title":"Circulating progenitor cell count predicts microvascular outcomes in type 2 diabetic patients","volume":"100","author":"Rigato","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.pharmthera.2016.10.014_bb0785","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1634\/stemcells.2005-0072","article-title":"Blood monocytes mimic endothelial progenitor cells","volume":"24","author":"Rohde","year":"2006","journal-title":"Stem Cells"},{"issue":"7","key":"10.1016\/j.pharmthera.2016.10.014_bb0790","doi-asserted-by":"crossref","first-page":"4339","DOI":"10.1074\/jbc.M509293200","article-title":"p53 mediates the accelerated onset of senescence of endothelial progenitor cells in diabetes","volume":"281","author":"Rosso","year":"2006","journal-title":"J Biol Chem"},{"issue":"6","key":"10.1016\/j.pharmthera.2016.10.014_bb0795","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S1050-1738(03)00106-3","article-title":"Circulating vascular progenitor cells contribute to vascular repair, remodeling, and lesion formation","volume":"13","author":"Sata","year":"2003","journal-title":"Trends Cardiovasc Med"},{"issue":"4","key":"10.1016\/j.pharmthera.2016.10.014_bb0800","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1172\/JCI9087","article-title":"Blood-derived angioblasts accelerate blood-flow restoration in diabetic mice","volume":"106","author":"Schatteman","year":"2000","journal-title":"J Clin Invest"},{"issue":"3","key":"10.1016\/j.pharmthera.2016.10.014_bb0805","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.diabet.2014.03.004","article-title":"Effects of glucose-lowering agents on vascular outcomes in type 2 diabetes: a critical reappraisal","volume":"40","author":"Scheen","year":"2014","journal-title":"Diabetes Metab"},{"issue":"22","key":"10.1016\/j.pharmthera.2016.10.014_bb0810","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.1161\/CIRCULATIONAHA.104.504340","article-title":"Reduced number of circulating endothelial progenitor cells predicts future cardiovascular events: proof of concept for the clinical importance of endogenous vascular repair","volume":"111","author":"Schmidt-Lucke","year":"2005","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.pharmthera.2016.10.014_bb0815","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1161\/CIRCRESAHA.107.169375","article-title":"Leptin enhances the recruitment of endothelial progenitor cells into neointimal lesions after vascular injury by promoting integrin-mediated adhesion","volume":"103","author":"Schroeter","year":"2008","journal-title":"Circ Res"},{"issue":"9","key":"10.1016\/j.pharmthera.2016.10.014_bb0820","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1161\/01.CIR.0000157156.85397.A1","article-title":"p38 mitogen-activated protein kinase downregulates endothelial progenitor cells","volume":"111","author":"Seeger","year":"2005","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.pharmthera.2016.10.014_bb0825","doi-asserted-by":"crossref","first-page":"102","DOI":"10.2337\/diabetes.55.01.06.db05-0803","article-title":"Nitric oxide cytoskeletal-induced alterations reverse the endothelial progenitor cell migratory defect associated with diabetes","volume":"55","author":"Segal","year":"2006","journal-title":"Diabetes"},{"issue":"12","key":"10.1016\/j.pharmthera.2016.10.014_bb0830","doi-asserted-by":"crossref","first-page":"2216","DOI":"10.1016\/j.bbadis.2013.08.006","article-title":"Endothelial dysfunction \u2014 a major mediator of diabetic vascular disease","volume":"1832","author":"Sena","year":"2013","journal-title":"Biochim Biophys Acta"},{"issue":"Suppl. 2","key":"10.1016\/j.pharmthera.2016.10.014_bb0835","first-page":"A13829","article-title":"Abstract 13829: Endothelial insulin sensitisation enhances vascular repair in systemic insulin resistance and improves endothelial function by restoring nitric oxide bioavailability","volume":"130","author":"Sengupta","year":"2014","journal-title":"Circulation"},{"issue":"12","key":"10.1016\/j.pharmthera.2016.10.014_bb0840","doi-asserted-by":"crossref","first-page":"3662","DOI":"10.1182\/blood-2006-06-030577","article-title":"Angiogenic cells can be rapidly mobilized and efficiently harvested from the blood following treatment with AMD3100","volume":"108","author":"Shepherd","year":"2006","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.pharmthera.2016.10.014_bb0845","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1161\/ATVBAHA.111.229260","article-title":"Oxidized low-density lipoprotein activates p66shc via lectin-like oxidized low-density lipoprotein receptor-1, protein kinase C-, and c-Jun N-terminal kinase in human endothelial cells","volume":"31","author":"Shi","year":"2011","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"8","key":"10.1016\/j.pharmthera.2016.10.014_bb0850","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1007\/s00125-009-1401-0","article-title":"Circulating endothelial progenitor cells, endothelial function, carotid intima\u2013media thickness and circulating markers of endothelial dysfunction in people with type 1 diabetes without macrovascular disease or microalbuminuria","volume":"52","author":"Sibal","year":"2009","journal-title":"Diabetologia"},{"issue":"4","key":"10.1016\/j.pharmthera.2016.10.014_bb0855","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1160\/TH14-11-0907","article-title":"Treprostinil indirectly regulates endothelial colony forming cell angiogenic properties by increasing VEGF-A produced by mesenchymal stem cells","volume":"114","author":"Smadja","year":"2015","journal-title":"Thromb Haemost"},{"issue":"1","key":"10.1016\/j.pharmthera.2016.10.014_bb9000","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.trsl.2007.02.002","article-title":"The establishment of murine blood outgrowth endothelial cells and observations relevant to gene therapy","volume":"150","author":"Somani","year":"2007","journal-title":"Transl Res"},{"issue":"2","key":"10.1016\/j.pharmthera.2016.10.014_bb0860","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1161\/CIRCULATIONAHA.106.684381","article-title":"Oxidant stress impairs in vivo reendothelialization capacity of endothelial progenitor cells from patients with type 2 diabetes mellitus: restoration by the peroxisome proliferator-activated receptor- agonist rosiglitazone","volume":"116","author":"Sorrentino","year":"2007","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.pharmthera.2016.10.014_bb0865","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1161\/CIRCULATIONAHA.108.836346","article-title":"Endothelial-vasoprotective effects of high-density lipoprotein are impaired in patients with type 2 diabetes mellitus but are improved after extended-release niacin therapy","volume":"121","author":"Sorrentino","year":"2010","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.pharmthera.2016.10.014_bb0870","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1161\/CIRCRESAHA.112.300598","article-title":"Global remodeling of the vascular stem cell niche in bone marrow of diabetic patients: implication of the microRNA-155\/FOXO3a signaling pathway","volume":"112","author":"Spinetti","year":"2013","journal-title":"Circ Res"},{"issue":"3","key":"10.1016\/j.pharmthera.2016.10.014_bb0875","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1161\/HYPERTENSIONAHA.109.134213","article-title":"Endothelial-regenerating cells: an expanding universe","volume":"55","author":"Steinmetz","year":"2010","journal-title":"Hypertension"},{"issue":"3","key":"10.1016\/j.pharmthera.2016.10.014_bb0880","first-page":"411","article-title":"Introduction to next generation of endothelial progenitor cell therapy: a promise in vascular medicine","volume":"7","author":"Sukmawati","year":"2015","journal-title":"Am J Transl Res"},{"issue":"1","key":"10.1016\/j.pharmthera.2016.10.014_bb0885","first-page":"482","article-title":"Vaspin alleviates dysfunction of endothelial progenitor cells induced by high glucose via PI3K\/Akt\/eNOS pathway","volume":"8","author":"Sun","year":"2015","journal-title":"Int J Clin Exp Pathol"},{"issue":"5","key":"10.1016\/j.pharmthera.2016.10.014_bb0890","doi-asserted-by":"crossref","first-page":"665","DOI":"10.6061\/clinics\/2013(05)14","article-title":"Effects of ACE inhibition on endothelial progenitor cell mobilization and prognosis after acute myocardial infarction in type 2 diabetic patients","volume":"68","author":"Sun","year":"2013","journal-title":"Clinics"},{"issue":"1","key":"10.1016\/j.pharmthera.2016.10.014_bb0895","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s11154-010-9134-4","article-title":"Endothelial dysfunction in diabetes mellitus: molecular mechanisms and clinical implications","volume":"11","author":"Tabit","year":"2010","journal-title":"Rev Endocr Metab Disord"},{"issue":"4","key":"10.1016\/j.pharmthera.2016.10.014_bb0900","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/7434","article-title":"Ischemia-and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization","volume":"5","author":"Takahashi","year":"1999","journal-title":"Nat Med"},{"issue":"2","key":"10.1016\/j.pharmthera.2016.10.014_bb0905","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/S0002-9440(10)63136-7","article-title":"Impairment in ischemia-induced neovascularization in diabetes: bone marrow mononuclear cell dysfunction and therapeutic potential of placenta growth factor treatment","volume":"164","author":"Tamarat","year":"2004","journal-title":"Am J Pathol"},{"issue":"2","key":"10.1016\/j.pharmthera.2016.10.014_bb0910","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.exer.2010.05.012","article-title":"Impaired function of circulating CD34+ CD45\u2212 cells in patients with proliferative diabetic retinopathy","volume":"91","author":"Tan","year":"2010","journal-title":"Exp Eye Res"},{"issue":"1","key":"10.1016\/j.pharmthera.2016.10.014_bb0915","doi-asserted-by":"crossref","first-page":"7","DOI":"10.2165\/11594650-000000000-00000","article-title":"Pharmacologic prevention of microvascular and macrovascular complications in diabetes mellitus: implications of the results of recent clinical trials in type 2 diabetes","volume":"12","author":"Tandon","year":"2012","journal-title":"Am J Cardiovasc Drugs"},{"issue":"2","key":"10.1016\/j.pharmthera.2016.10.014_bb0920","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1161\/CIRCULATIONAHA.108.817528","article-title":"Diabetes mellitus activates signal transduction pathways resulting in vascular endothelial growth factor resistance of human monocytes","volume":"120","author":"Tchaikovski","year":"2009","journal-title":"Circulation"},{"issue":"22","key":"10.1016\/j.pharmthera.2016.10.014_bb0925","doi-asserted-by":"crossref","first-page":"2781","DOI":"10.1161\/01.CIR.0000039526.42991.93","article-title":"Human endothelial progenitor cells from type II diabetics exhibit impaired proliferation, adhesion, and incorporation into vascular structures","volume":"106","author":"Tepper","year":"2002","journal-title":"Circulation"},{"issue":"10","key":"10.1016\/j.pharmthera.2016.10.014_bb0930","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1161\/CIRCULATIONAHA.114.012913","article-title":"Effect of repetitive intra-arterial infusion of bone marrow mononuclear cells in patients with no-option limb ischemia: the randomized, double-blind, placebo-controlled JUVENTAS trial","volume":"131","author":"Teraa","year":"2015","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.pharmthera.2016.10.014_bb0935","doi-asserted-by":"crossref","first-page":"666","DOI":"10.2337\/db06-0699","article-title":"Endothelial nitric oxide synthase uncoupling impairs endothelial progenitor cell mobilization and function in diabetes","volume":"56","author":"Thum","year":"2007","journal-title":"Diabetes"},{"issue":"10","key":"10.1016\/j.pharmthera.2016.10.014_bb0940","doi-asserted-by":"crossref","first-page":"E1120","DOI":"10.1152\/ajpendo.00696.2013","article-title":"GTP cyclohydrolase I prevents diabetic-impaired endothelial progenitor cells and wound healing by suppressing oxidative stress\/thrombospondin-1","volume":"306","author":"Tie","year":"2014","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.pharmthera.2016.10.014_bb0945","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/j.1582-4934.2008.00598.x","article-title":"Endothelial progenitor cells: identity defined?","volume":"13","author":"Timmermans","year":"2009","journal-title":"J Cell Mol Med"},{"issue":"22","key":"10.1016\/j.pharmthera.2016.10.014_bb0950","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.1001\/jama.2012.28726","article-title":"Effect of the use and timing of bone marrow mononuclear cell delivery on left ventricular function after acute myocardial infarction: the TIME randomized trial","volume":"308","author":"Traverse","year":"2012","journal-title":"JAMA"},{"issue":"24","key":"10.1016\/j.pharmthera.2016.10.014_bb0955","doi-asserted-by":"crossref","first-page":"3872","DOI":"10.1038\/sj.onc.1205513","article-title":"A p53-p66Shc signaling pathway controls intracellular redox status, levels of oxidation-damaged DNA and oxidative stress-induced apoptosis","volume":"21","author":"Trinei","year":"2002","journal-title":"Oncogene"},{"issue":"4","key":"10.1016\/j.pharmthera.2016.10.014_bb0960","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.2337\/db12-0646","article-title":"Increase of palmitic acid concentration impairs endothelial progenitor cell and bone marrow-derived progenitor cell bioavailability: role of the stat5\/ppar transcriptional complex","volume":"62","author":"Trombetta","year":"2013","journal-title":"Diabetes"},{"issue":"2","key":"10.1016\/j.pharmthera.2016.10.014_bb0965","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1002\/stem.1280","article-title":"Late outgrowth endothelial cells resemble mature endothelial cells and are not derived from bone marrow","volume":"31","author":"Tura","year":"2013","journal-title":"Stem Cells"},{"issue":"7","key":"10.1016\/j.pharmthera.2016.10.014_bb0970","doi-asserted-by":"crossref","first-page":"5141","DOI":"10.4049\/jimmunol.180.7.5141","article-title":"The presence of activated CD4+ T cells is essential for the formation of colony-forming unit-endothelial cells by CD14+ cells","volume":"180","author":"van Beem","year":"2008","journal-title":"J Immunol"},{"issue":"6","key":"10.1016\/j.pharmthera.2016.10.014_bb0975","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1161\/HYPERTENSIONAHA.114.04221","article-title":"Endothelial dysfunction plays a key role in increasing cardiovascular risk in type 2 diabetes: the Hoorn study","volume":"64","author":"van Sloten","year":"2014","journal-title":"Hypertension"},{"issue":"25","key":"10.1016\/j.pharmthera.2016.10.014_bb0980","doi-asserted-by":"crossref","first-page":"22370","DOI":"10.1074\/jbc.M200280200","article-title":"The p66Shc longevity gene is silenced through epigenetic modifications of an alternative promoter","volume":"277","author":"Ventura","year":"2002","journal-title":"J Biol Chem"},{"issue":"17","key":"10.1016\/j.pharmthera.2016.10.014_bb0985","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1161\/01.CIR.0000127577.63323.24","article-title":"C-reactive protein attenuates endothelial progenitor cell survival, differentiation, and function: further evidence of a mechanistic link between C-reactive protein and cardiovascular disease","volume":"109","author":"Verma","year":"2004","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.pharmthera.2016.10.014_bb0990","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1111\/j.1365-2796.2008.02011.x","article-title":"Diabetes mellitus impairs CD133+ progenitor cell function after myocardial infarction","volume":"265","author":"V\u00f6\u00f6","year":"2009","journal-title":"J Intern Med"},{"issue":"2","key":"10.1016\/j.pharmthera.2016.10.014_bb0995","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1093\/cvr\/cvt259","article-title":"Glyoxalase-1 overexpression in bone marrow cells reverses defective neovascularization in STZ-induced diabetic mice","volume":"101","author":"Vulesevic","year":"2014","journal-title":"Cardiovasc Res"},{"issue":"11","key":"10.1016\/j.pharmthera.2016.10.014_bb1000","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1161\/01.CIR.0000123231.49594.21","article-title":"Rosiglitazone facilitates angiogenic progenitor cell differentiation toward endothelial lineage: a new paradigm in glitazone pleiotropy","volume":"109","author":"Wang","year":"2004","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.pharmthera.2016.10.014_bb1005","first-page":"R586","article-title":"Factors associated with purity, biological function, and activation potential of endothelial colony-forming cells","volume":"300","author":"Wang","year":"2011","journal-title":"Am J Phys Regul Integr Comp Phys"},{"issue":"1","key":"10.1016\/j.pharmthera.2016.10.014_bb1010","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1161\/ATVBAHA.113.302104","article-title":"MicroRNA miR-27b rescues bone marrow-derived angiogenic cell function and accelerates wound healing in type 2 diabetes mellitus","volume":"34","author":"Wang","year":"2014","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"6","key":"10.1016\/j.pharmthera.2016.10.014_bb1015","doi-asserted-by":"crossref","first-page":"1051.e1","DOI":"10.1016\/j.ahj.2006.07.029","article-title":"Pioglitazone increases the numbers and improves the functional capacity of endothelial progenitor cells in patients with diabetes mellitus","volume":"152","author":"Wang","year":"2006","journal-title":"Am Heart J"},{"issue":"6","key":"10.1016\/j.pharmthera.2016.10.014_bb1020","doi-asserted-by":"crossref","first-page":"E1135","DOI":"10.1152\/ajpendo.00001.2011","article-title":"AMP-activated protein kinase rescues the angiogenic functions of endothelial progenitor cells via manganese superoxide dismutase induction in type 1 diabetes","volume":"300","author":"Wang","year":"2011","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.pharmthera.2016.10.014_bb1025","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.atherosclerosis.2007.10.003","article-title":"Mechanisms underlying recoupling of eNOS by HMG-CoA reductase inhibition in a rat model of streptozotocin-induced diabetes mellitus","volume":"198","author":"Wenzel","year":"2008","journal-title":"Atherosclerosis"},{"issue":"10","key":"10.1016\/j.pharmthera.2016.10.014_bb1030","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1056\/NEJMoa043814","article-title":"Circulating endothelial progenitor cells and cardiovascular outcomes","volume":"353","author":"Werner","year":"2005","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.pharmthera.2016.10.014_bb1035","doi-asserted-by":"crossref","first-page":"2685","DOI":"10.1111\/bph.12608","article-title":"The dual PPAR\u03b1\/\u03b3 agonist aleglitazar increases the number and function of endothelial progenitor cells: implications for vascular function and atherogenesis: vascular effects of aleglitazar","volume":"171","author":"Werner","year":"2014","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pharmthera.2016.10.014_bb1045","doi-asserted-by":"crossref","first-page":"1943918","DOI":"10.1155\/2016\/1943918","article-title":"Diabetes-induced oxidative stress in endothelial progenitor cells may be sustained by a positive feedback loop involving high mobility group Box-1","volume":"2016","author":"Wu","year":"2016","journal-title":"Oxidative Med Cell Longev"},{"issue":"4","key":"10.1016\/j.pharmthera.2016.10.014_bb1050","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1016\/j.ijcard.2012.03.167","article-title":"A potent soluble epoxide hydrolase inhibitor, t-AUCB, acts through PPAR\u03b3 to modulate the function of endothelial progenitor cells from patients with acute myocardial infarction","volume":"167","author":"Xu","year":"2013","journal-title":"Int J Cardiol"},{"issue":"6","key":"10.1016\/j.pharmthera.2016.10.014_bb1055","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1016\/j.jvs.2009.08.007","article-title":"Recovery from hind limb ischemia is less effective in type 2 than in type 1 diabetic mice: roles of endothelial nitric oxide synthase and endothelial progenitor cells","volume":"50","author":"Yan","year":"2009","journal-title":"J Vasc Surg"},{"issue":"6","key":"10.1016\/j.pharmthera.2016.10.014_bb1060","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1161\/ATVBAHA.109.191635","article-title":"Is endothelium the origin of endothelial progenitor cells?","volume":"30","author":"Yoder","year":"2010","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"16","key":"10.1016\/j.pharmthera.2016.10.014_bb1065","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1161\/01.CIR.0000162472.52990.36","volume":"111","author":"Yoon","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2016.10.014_bb1070","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/s12933-016-0408-3","article-title":"Metformin improves the angiogenic functions of endothelial progenitor cells via activating AMPK\/eNOS pathway in diabetic mice","volume":"15","author":"Yu","year":"2016","journal-title":"Cardiovasc Diabetol"},{"issue":"4","key":"10.1016\/j.pharmthera.2016.10.014_bb1075","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/j.bbrc.2015.02.050","article-title":"Accelerated onset of senescence of endothelial progenitor cells in patients with type 2 diabetes mellitus: role of dimethylarginine dimethylaminohydrolase 2 and asymmetric dimethylarginine","volume":"458","author":"Yuan","year":"2015","journal-title":"Biochem Biophys Res Commun"},{"issue":"4","key":"10.1016\/j.pharmthera.2016.10.014_bb1080","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.stem.2009.02.013","article-title":"Synergy between CD26\/DPP-IV inhibition and G-CSF improves cardiac function after acute myocardial infarction","volume":"4","author":"Zaruba","year":"2009","journal-title":"Cell Stem Cell"},{"issue":"4","key":"10.1016\/j.pharmthera.2016.10.014_bb1085","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1161\/ATVBAHA.107.160044","article-title":"Ex vivo priming of endothelial progenitor cells with SDF-1 before transplantation could increase their proangiogenic potential","volume":"28","author":"Zemani","year":"2008","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"6","key":"10.1016\/j.pharmthera.2016.10.014_bb1090","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1161\/ATVBAHA.114.303809","article-title":"Stem\/progenitor cells in vascular regeneration","volume":"34","author":"Zhang","year":"2014","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"5","key":"10.1016\/j.pharmthera.2016.10.014_bb1095","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1096\/fj.08-110296","article-title":"Premature senescence of highly proliferative endothelial progenitor cells is induced by tumor necrosis factor-alpha via the p38 mitogen-activated protein kinase pathway","volume":"23","author":"Zhang","year":"2009","journal-title":"FASEB J"},{"key":"10.1016\/j.pharmthera.2016.10.014_bb1100","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.plipres.2013.11.003","article-title":"Stabilized epoxygenated fatty acids regulate inflammation, pain, angiogenesis and cancer","volume":"53","author":"Zhang","year":"2014","journal-title":"Prog Lipid Res"},{"issue":"1","key":"10.1016\/j.pharmthera.2016.10.014_bb1105","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1177\/1479164112444639","article-title":"Hyperglycaemia exerts deleterious effects on late endothelial progenitor cell secretion actions","volume":"10","author":"Zhang","year":"2013","journal-title":"Diab Vasc Dis Res"},{"issue":"5","key":"10.1016\/j.pharmthera.2016.10.014_bb1110","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1111\/j.1538-7836.2006.01906.x","article-title":"G-CSF-mobilized peripheral blood mononuclear cells from diabetic patients augment neovascularization in ischemic limbs but with impaired capability","volume":"4","author":"Zhou","year":"2006","journal-title":"J Thromb Haemost"},{"issue":"6","key":"10.1016\/j.pharmthera.2016.10.014_bb8000","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1161\/CIRCRESAHA.111.243592","article-title":"Repression of P66Shc expression by SIRT1 contributes to the prevention of hyperglycemia-induced endothelial dysfunction","volume":"109","author":"Zhou","year":"2011","journal-title":"Circ Res"},{"key":"10.1016\/j.pharmthera.2016.10.014_bb1115","doi-asserted-by":"crossref","DOI":"10.1016\/j.jvs.2016.03.407","article-title":"Poly-ADP-ribose polymerase inhibition enhances ischemic and diabetic wound healing by promoting angiogenesis","author":"Zhou","year":"2016","journal-title":"J Vasc Surg"}],"container-title":["Pharmacology & Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725816301930?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725816301930?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,14]],"date-time":"2019-09-14T17:45:00Z","timestamp":1568483100000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163725816301930"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2]]},"references-count":220,"alternative-id":["S0163725816301930"],"URL":"https:\/\/doi.org\/10.1016\/j.pharmthera.2016.10.014","relation":{},"ISSN":["0163-7258"],"issn-type":[{"value":"0163-7258","type":"print"}],"subject":[],"published":{"date-parts":[[2017,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Modulating putative endothelial progenitor cells for the treatment of endothelial dysfunction and cardiovascular complications in diabetes","name":"articletitle","label":"Article Title"},{"value":"Pharmacology & Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharmthera.2016.10.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}